SCA
TMDX icon

Summit Creek Advisors’s Transmedics TMDX Stock Holding History

Summit Creek Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.77M Buy
+26,707
New +$2.26M 0.6% 52

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Summit Creek Advisors's TMDX Position: Q2 2026 in Review

Summit Creek Advisors opened a new position in Transmedics (TMDX) in Q2 2026: 26,707 shares worth $1.77M. The stake represents 0.6% of the portfolio and ranks #52 among its holdings.

322 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Summit Creek Advisors held 26,707 shares of Transmedics worth $1.77M as of Q2 2026.
  • Transmedics was a new Summit Creek Advisors position in Q2 2026.
  • Transmedics made up 0.6% of Summit Creek Advisors's portfolio in Q2 2026, its #52 holding.
  • 322 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Summit Creek Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.